Sumi-og, Diomedes F.
HRN: 22-20-54 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFTRIAXONE 1G (VIAL)
11/19/2022
11/26/2022
IVTT
2g
Q24
Typhoid Fever
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes